Back to Agenda
SESSION2-1: East-Asian Regulatory Update on Global Clinical Trials
Session Chair(s)
Yasuto Otsubo
Review Director, Office of New Drug II
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Minsoo Park
KCGI, Korea, Republic of
Speaker(s)
Tao Wang, MD, PhD
China Food and Drug Administration (CFDA), China
Director of Chemical Medicine Evaluation office II
Recent Status of Regulation and Clinical Trial in Korea
Myung-jung Kim, MS
Ministry of Food and Drug Safety (MFDS), Korea, Republic of
Director, Clinical Trials Management Division, Pharmaceutical Safety Bureau
Global Clinical Data Evaluation for Drug Approval in Japan
Yasuto Otsubo
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Review Director, Office of New Drug II
Have an account?